Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome b pseudogene 38 (MTCYBP38) is a noncoding pseudogene and does not produce the cytochrome b protein. It is distinct from the functional MT-CYB gene, which encodes cytochrome b—a mitochondrial electron transport chain protein critical for ATP synthesis and energy metabolism[2]. Pseudogenes like MTCYBP38 are remnants of gene duplication or mutation events and are generally considered nonfunctional in terms of protein coding or regulatory activity. They are not therapeutic targets and have no known roles in signal transduction, disease mechanism, or drug response[2]. Summary of key points: - MTCYBP38 is a pseudogene and does not encode a functional protein, nor is it a therapeutic target[2]. - All functional, clinical, and pharmacological relevance relates to the actual MT-CYB gene and its product, cytochrome b—not to MTCYBP38[2]. - There are no drugs, mechanisms, disease roles, biomarkers, or safety concerns relevant to MTCYBP38.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome b pseudogene 38 (MTCYBP38).